Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Malignant Lymphoma

  Free Subscription


28.06.2021

2 Am J Hematol
1 Am Surg
4 Blood
1 Bone Marrow Transplant
2 Br J Haematol
2 Cancer
4 Haematologica
1 J Clin Oncol
6 Leuk Lymphoma
1 Leukemia
1 Mod Pathol
1 Oncology (Williston Park)
1 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Hematol

  1. SARKOZY C, Michot JM, Quivoron C, Camara-Clayette V, et al
    Innovative therapies based on molecular orientation in patients with Relapse and Refractory diffuse large B cell lymphoma, results of LNH-EP1 study.
    Am J Hematol. 2021 Jun 24. doi: 10.1002/ajh.26280.
    PubMed        

  2. DEFRANCESCO I, Visentini M, Zibellini S, Minafo YA, et al
    Mutational and immunogenetic landscape of HCV-associated B-cell lymphoproliferative disorders.
    Am J Hematol. 2021;96:E210-E214.
    PubMed        


    Am Surg

  3. CHRISTOPHER WO, Fischer TD, Bilchik AJ
    Undifferentiated Carcinoma With Osteoclast-Like Giant Cells of the Pancreas Discovered on Positron Emission Tomography Performed for Lymphoma Staging.
    Am Surg. 2021 Jun 22:31348211029865. doi: 10.1177/00031348211029865.
    PubMed        


    Blood

  4. RULAND J
    Synergy of MALT1 and mTOR inhibition in DLBCL.
    Blood. 2021;137:724-725.
    PubMed        

  5. WIRTH A, Mikhaeel NG
    PET response-guided radiotherapy for advanced DLBCL?
    Blood. 2021;137:866-867.
    PubMed        

  6. MADDOCKS K
    Building on BTK inhibition in MCL.
    Blood. 2021;137:861-862.
    PubMed        

  7. REJESKI K, Perez Perez A, Sesques P, Hoster E, et al
    CAR-HEMATOTOX: A model for CAR T-cell related hematological toxicity in relapsed/refractory large B-cell lymphoma.
    Blood. 2021 Jun 24. pii: 476241. doi: 10.1182/blood.2020010543.
    PubMed         Abstract available


    Bone Marrow Transplant

  8. MERLI M, Luminari S, Farina L, Cocito F, et al
    Stem cell mobilization after bendamustine in indolent lymphomas: a multicenter study on behalf of the Fondazione Italiana Linfomi.
    Bone Marrow Transplant. 2020 Jun 15. pii: 10.1038/s41409-020-0967.
    PubMed        


    Br J Haematol

  9. BUSSOT L, Chevalier S, Cristante J, Grange B, et al
    Adverse outcome in follicular lymphoma is associated with MYC rearrangements but not MYC extra copies.
    Br J Haematol. 2021 Jun 21. doi: 10.1111/bjh.17550.
    PubMed         Abstract available

  10. MIKHAEEL NG, Cunningham D, Counsell N, McMillan A, et al
    FDG-PET/CT after two cycles of R-CHOP in DLBCL predicts complete remission but has limited value in identifying patients with poor outcome - final result of a UK National Cancer Research Institute prospective study.
    Br J Haematol. 2021;192:504-513.
    PubMed         Abstract available


    Cancer

  11. EL-GALALY TC, Ovlisen AK, Cheah CY
    Routine imaging for disease surveillance in follicular lymphoma-To comfort the patients or their doctors?
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33659.
    PubMed        

  12. GOLDMAN ML, Mao JJ, Strouse CS, Chen W, et al
    Surveillance imaging during first remission in follicular lymphoma does not impact overall survival.
    Cancer. 2021 Jun 22. doi: 10.1002/cncr.33660.
    PubMed         Abstract available


    Haematologica

  13. RULE S, Barreto WG, Briones J, Carella AM, et al
    Efficacy and safety assessment of prolonged maintenance with subcutaneous rituximab in patients with relapsed or refractory indolent non-Hodgkin lymphoma: results of the Phase III MabCute study.
    Haematologica. 2021 Jun 17. doi: 10.3324/haematol.2020.274803.
    PubMed         Abstract available

  14. NAPOLI S, Cascione L, Rinaldi A, Spriano F, et al
    Characterization of GECPAR, a noncoding RNA that regulates the transcriptional program of diffuse large B cell lymphoma.
    Haematologica. 2021 Jun 24. doi: 10.3324/haematol.2020.267096.
    PubMed         Abstract available

  15. EVENS AM, Connors JM, Younes A, Ansell SM, et al
    Older patients (aged >/=60 years) with previously untreated advanced-stage classical Hodgkin lymphoma: a detailed analysis from the phase III ECHELON-1 study.
    Haematologica. 2021 Jun 24. doi: 10.3324/haematol.2021.278438.
    PubMed         Abstract available

  16. BENKLI CY, Marcogliese AN, Agrusa JE, Adesina AM, et al
    Clinical genomic profiling of novel grey zone lymphoma paired lesions with sequential central nervous system involvement in two adolescent patients.
    Haematologica. 2021 Jun 24. doi: 10.3324/haematol.2021.278936.
    PubMed         Abstract available


    J Clin Oncol

  17. DEMEESTERE I, Racape J, Dechene J, Dupuis J, et al
    Gonadal Function Recovery in Patients With Advanced Hodgkin Lymphoma Treated With a PET-Adapted Regimen: Prospective Analysis of a Randomized Phase III Trial (AHL2011).
    J Clin Oncol. 2021 Jun 22:JCO2100068. doi: 10.1200/JCO.21.00068.
    PubMed         Abstract available


    Leuk Lymphoma

  18. OU YC, Tang Z, Novotny W, Cohen A, et al
    Rationale for once-daily or twice-daily dosing of zanubrutinib in patients with mantle cell lymphoma.
    Leuk Lymphoma. 2021 Jun 23:1-13. doi: 10.1080/10428194.2021.1929961.
    PubMed         Abstract available

  19. XIAO Z, Mo Y, Long W, Li R, et al
    Value of baseline and end of chemotherapy (18)F-FDG PET/CT in pediatric patients with Burkitt lymphoma.
    Leuk Lymphoma. 2021 Jun 24:1-9. doi: 10.1080/10428194.2021.1941933.
    PubMed         Abstract available

  20. ELGAAFARY S, Lopez C, Nagel I, Vater I, et al
    Molecular characterization of Burkitt lymphoma in the breast or ovary.
    Leuk Lymphoma. 2021 Jun 24:1-10. doi: 10.1080/10428194.2021.1907374.
    PubMed         Abstract available

  21. MESSMER M, Wagner-Johnston N
    COVID-19 vaccination in patients on rituximab: a survey of lymphoma physicians at NCI designated cancer centers.
    Leuk Lymphoma. 2021 Jun 21:1-4. doi: 10.1080/10428194.2021.1941939.
    PubMed        

  22. CASTILLO JJ, Beltran BE, Malpica L, Marques-Piubelli ML, et al
    Anaplastic lymphoma kinase-positive large B-cell lymphoma (ALK + LBCL): a systematic review of clinicopathological features and management.
    Leuk Lymphoma. 2021 Jun 21:1-9. doi: 10.1080/10428194.2021.1941929.
    PubMed         Abstract available

  23. HUSBY S, Favero F, Rodriguez-Gonzalez FG, Sutton LA, et al
    Mutations known from B-cell lymphoid malignancies are not found in CD34(+) stem cells from patients with lymphoma.
    Leuk Lymphoma. 2021 Jun 21:1-4. doi: 10.1080/10428194.2021.1933473.
    PubMed        


    Leukemia

  24. GRAHAM CE, Jozwik A, Quartey-Papafio R, Ioannou N, et al
    Gene-edited healthy donor CAR T cells show superior anti-tumour activity compared to CAR T cells derived from patients with lymphoma in an in vivo model of high-grade lymphoma.
    Leukemia. 2021 Jun 18. pii: 10.1038/s41375-021-01324.
    PubMed        


    Mod Pathol

  25. EVANS MG, Medeiros LJ, Marques-Piubelli ML, Wang HY, et al
    Breast implant-associated anaplastic large cell lymphoma: clinical follow-up and analysis of sequential pathologic specimens of untreated patients shows persistent or progressive disease.
    Mod Pathol. 2021 Jun 21. pii: 10.1038/s41379-021-00842.
    PubMed         Abstract available


    Oncology (Williston Park)

  26. SALAMA M, Isachenko E, Rahimi G, Mallmann P, et al
    Emergency Fertility Preservation in a Young Woman With Non-Hodgkin Lymphoma.
    Oncology (Williston Park). 2021;35:332-334.
    PubMed         Abstract available


    PLoS One

  27. TAKASHIMA Y, Kawaguchi A, Fukai J, Iwadate Y, et al
    Survival prediction based on the gene expression associated with cancer morphology and microenvironment in primary central nervous system lymphoma.
    PLoS One. 2021;16:e0251272.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Lymphoma is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: